Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 290

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Individualized therapy for persistent asthma in young children

Open access
Fitzpatrick, Anne M., Jackson, Daniel J., Mauger, David T., Boehmer, Susan J., Phipatanakul, Wanda, Sheehan, William J., Moy, James N., Paul, Ian M., Bacharier, Leonard B., Cabana, Michael D., Covar, Ronina, Holguin, Fernando, Lemanske, Robert F., Martinez, Fernando D., Pongracic, Jacqueline A., Beigelman, Avraham, Baxi, Sachin N., Benson, Mindy, Blake, Kathryn, Chmiel, James F., Daines, Cori L., Daines, Michael O., Gaffin, Jonathan M., Gentile, Deborah Ann, Gower, W. Adam, Israel, Elliot, Kumar, Harsha Vardhan, Lang, Jason E., Lazarus, Stephen C., Lima, John J., Ly, Ngoc, Marbin, Jyothi, Morgan, Wayne, Myers, Ross E., Olin, J. Tod, Peters, Stephen P., Raissy, Hengameh H., Robison, Rachel G., Ross, Kristie, Sorkness, Christine A., Thyne, Shannon M., Szefler, Stanley J.·2016·Journal of Allergy and Clinical Immunology

Abstract

Background Phenotypic presentations in young children with asthma are varied and may contribute to differential responses to asthma controller medications. Methods The Individualized Therapy for Asthma in Toddlers (INFANT) study was a multicenter, randomized, double-blind, double-dummy, clinical trial in children age 12-59 months (n=300) with asthma necessitating treatment with daily controller (Step 2) therapy. Participants completed a 2-8 week run-in period followed by three crossover periods with daily inhaled corticosteroid (ICS), daily leukotriene receptor antagonist (LTRA), and as-needed ICS treatment co-administered with albuterol. The primary outcome was differential response to asthma medication based on a composite measure of asthma control. The primary analysis involved two stages: determination of differential response, and assessment of whether three pre-specified features (aeroallergen sensitization, previous exacerbations, sex) predicted differential response. Results 74% (170 of 230) of children with analyzable data had a differential response to the three treatment strategies. Within differential responders, the probability of best response was highest for daily ICS and was predicted by aeroallergen sensitization, but not exacerbation history or sex. The probability of best response to daily ICS was further increased in children with both aeroallergen sensitization and blood eosinophils ≥300/μL. In these children, daily ICS was associated with more asthma control days and fewer exacerbations compared to the other treatments. Conclusions In young children with asthma necessitating Step 2 treatment, phenotyping with aeroallergen sensitization and blood eosinophils is useful for guiding treatment selection and identifies children with a high exacerbation probability for whom treatment with daily ICS is beneficial despite possible risks of growth suppression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2016.09.028

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 290

Metadata

Authors
Fitzpatrick, A. M., Jackson, D. J., Mauger, D. T., Boehmer, S. J., Phipatanakul, W., Sheehan, W. J., Moy, J. N., Paul, I. M., Bacharier, L. B., Cabana, M. D., Covar, R., Holguin, F., Lemanske, R. F., Martinez, F. D., Pongracic, J. A., Beigelman, A., Baxi, S. N., Benson, M., Blake, K., Chmiel, J. F., Daines, C. L., Daines, M. O., Gaffin, J. M., Gentile, D. A., Gower, W. A., Israel, E., Kumar, H. V., Lang, J. E., Lazarus, S. C., Lima, J. J., Ly, N., Marbin, J., Morgan, W., Myers, R. E., Olin, J. T., Peters, S. P., Raissy, H. H., Robison, R. G., Ross, K., Sorkness, C. A., Thyne, S. M., & Szefler, S. J.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2016-12
Volume
138
Issue
6
Pages
1608-1618.e12
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2533342247
Cited by
290
References
52
FWCI
20.53
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Individualized therapy for persistent asthma in young children. https://app.cochat.ai/papers/10.1016/j.jaci.2016.09.028
The paper
Fitzpatrick, A. M., Jackson, D. J., Mauger, D. T., Boehmer, S. J., Phipatanakul, W., Sheehan, W. J., Moy, J. N., Paul, I. M., Bacharier, L. B., Cabana, M. D., Covar, R., Holguin, F., Lemanske, R. F., Martinez, F. D., Pongracic, J. A., Beigelman, A., Baxi, S. N., Benson, M., Blake, K., . . . Szefler, S. J. (2016). Individualized therapy for persistent asthma in young children. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2016.09.028

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.